LUCA Science Raises ¥3.86 Billion ($30.3 Million) in Oversubscribed Series B Financing
yahoo.com
news
2022-06-06 07:00:00

Series B co-led by Fast Track Initiative, DCI Partners, and 4BIO Capital

Proceeds to accelerate development of LUCA's novel Mitochondria Isolation Technology (MIT) platform, IND-enabling activities for its in-house pipeline and establish its manufacturing capability

TOKYO, June 06, 2022--(BUSINESS WIRE)--LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutical agents, today announced the closing of a ¥3.86 billion (USD 30.3 million) oversubscribed Series B financing.
